AI-10-49 is a selective inhibitor of the binding of CBFβ-SMMHC to RUNX1 with IC50 of 260 nM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 87 | |
4 mg | In stock | $ 147 | |
8 mg | In stock | $ 231 | |
20 mg | In stock | $ 458 | |
40 mg | In stock | $ 728 |
Description | AI-10-49 is a selective inhibitor of the binding of CBFβ-SMMHC to RUNX1 with IC50 of 260 nM. |
Targets&IC50 | CBFβ-SMMHC:260 nM |
In vitro | AI-10-49 displays specific growth inhibition of inv(16)-positive cell line ME-1. AI-10-49 selectively binds to CBFβ-SMMHC, disrupts its binding to RUNX1, and restores RUNX1 transcriptional activity. |
In vivo | In mice transplanted with Cbfb+/MYH11;Nras+/G12D leukemic cells, AI-10-49 (200 mg/kg, i.p.) reduces leukemia expansion. |
CAS No. | 1256094-72-0 |
Chemical Formula | C30H22F6N6O5 |
Molecular Weight | 660.533 |
Solubility | Ethanol: 93 mg/mL (140.8 mM) H2O: <1 mg/mL; DMSO: 93 mg/mL (140.8 mM) |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom